Captisol® Modified Cyclodextrin from Ligand Pharmaceuticals

Description

Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, stability, bioavailability and dosing of active pharmaceutical ingredients (APIs). Captisol is currently in 15 FDA Approved Products.